Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 22226094)


Clinical applications for biomarkers of acute and chronic graft-versus-host disease.

Levine JE, Paczesny S, Sarantopoulos S.

Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S116-24. doi: 10.1016/j.bbmt.2011.10.019. Review.


Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning.

Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M.

Biol Blood Marrow Transplant. 2012 Nov;18(11):1727-33. doi: 10.1016/j.bbmt.2012.06.014. Epub 2012 Jul 2.


Biomarkers in chronic graft-versus-host disease.

Rozmus J, Schultz KR.

Expert Rev Hematol. 2011 Jun;4(3):329-42. doi: 10.1586/ehm.11.27. Review.


Discovery and validation of graft-versus-host disease biomarkers.

Paczesny S.

Blood. 2013 Jan 24;121(4):585-94. doi: 10.1182/blood-2012-08-355990. Epub 2012 Nov 19. Review.


Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.

Cho BS, Lee SE, Song HH, Lee JH, Yahng SA, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW.

Biol Blood Marrow Transplant. 2012 Jul;18(7):1136-43. doi: 10.1016/j.bbmt.2012.01.010. Epub 2012 Jan 16.


Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

Schultz KR, Miklos DB, Fowler D, Cooke K, Shizuru J, Zorn E, Holler E, Ferrara J, Shulman H, Lee SJ, Martin P, Filipovich AH, Flowers ME, Weisdorf D, Couriel D, Lachenbruch PA, Mittleman B, Vogelsang GB, Pavletic SZ.

Biol Blood Marrow Transplant. 2006 Feb;12(2):126-37.


Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.

Ukena SN, Geffers R, Buchholz S, Stadler M, Franzke A.

Transpl Immunol. 2012 Dec;27(4):179-83. doi: 10.1016/j.trim.2012.07.003. Epub 2012 Aug 4.


Expression of CD30 in patients with acute graft-versus-host disease.

Chen YB, McDonough S, Hasserjian R, Chen H, Coughlin E, Illiano C, Park IS, Jagasia M, Spitzer TR, Cutler CS, Soiffer RJ, Ritz J.

Blood. 2012 Jul 19;120(3):691-6. doi: 10.1182/blood-2012-03-415422. Epub 2012 Jun 1.


Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.

Pavletic SZ, Smith LM, Bishop MR, Lynch JC, Tarantolo SR, Vose JM, Bierman PJ, Hadi A, Armitage JO, Kessinger A.

Am J Hematol. 2005 Apr;78(4):265-74.


Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Lee KH, Choi SJ, Lee JH, Lee JS, Kim WK, Lee KB, Sohn SK, Kim JG, Kim DH, Seol M, Lee YS, Lee JH.

Haematologica. 2005 Jul;90(7):939-48.


Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

Moon JH, Sohn SK, Lambie A, Ellis L, Hamad N, Uhm J, Gupta V, Lipton JH, Messner HA, Kuruvilla J, Kim D.

Biol Blood Marrow Transplant. 2014 Apr;20(4):556-63. doi: 10.1016/j.bbmt.2014.01.010. Epub 2014 Jan 18.


Plasma biomarkers in graft-versus-host disease: a new era?

Paczesny S, Levine JE, Braun TM, Ferrara JL.

Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):33-8. doi: 10.1016/j.bbmt.2008.10.027. Review.


Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.

Xiao B, Wang Y, Li W, Baker M, Guo J, Corbet K, Tsalik EL, Li QJ, Palmer SM, Woods CW, Li Z, Chao NJ, He YW.

Blood. 2013 Nov 7;122(19):3365-75. doi: 10.1182/blood-2013-06-510586. Epub 2013 Sep 16.


Clinical update on graft-versus-host disease in children.

Goddard DS, Horn BN, McCalmont TH, Cordoro KM.

Semin Cutan Med Surg. 2010 Jun;29(2):92-105. doi: 10.1016/j.sder.2010.03.010. Review.


Extracorporeal photophoresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(6):1-82. Epub 2006 Mar 1.


Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.

Lo JW, Leung AY, Huang XR, Lie AK, Metz C, Bucala R, Liang R, Lan HY.

Bone Marrow Transplant. 2002 Sep;30(6):375-80.


Serum microRNA155 is increased in patients with acute graft-versus-host disease.

Xie LN, Zhou F, Liu XM, Fang Y, Yu Z, Song NX, Kong FS.

Clin Transplant. 2014 Mar;28(3):314-23. doi: 10.1111/ctr.12314. Epub 2014 Feb 4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk